PREVACID

This brand name is authorized in Canada, Singapore, United States

Active ingredients

The drug PREVACID contains one active pharmaceutical ingredient (API):

1 Lansoprazole UNII 0K5C5T2QPG - LANSOPRAZOLE

Lansoprazole is a gastric proton pump inhibitor. It inhibits the final stage of gastric acid formation by inhibiting the activity of H+/K+ ATPase of the parietal cells in the stomach. The inhibition is dose-dependent and reversible, and the effect applies to both basal and stimulated secretion of gastric acid. Read about Lansoprazole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PREVACID Delayed-release capsule / Delayed-release tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A02BC03	Lansoprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02165503, 02165511, 02249464, 02249472
Country: SG	Health Sciences Authority	Identifier(s): 08276P
Country: US	FDA, National Drug Code	Identifier(s): 55154-0253, 55289-704, 64764-046, 64764-541, 64764-543, 64764-544